| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | PWWP | 2.01e-06 | 20 | 87 | 4 | SM00293 | |
| Domain | PWWP | 3.63e-06 | 23 | 87 | 4 | PF00855 | |
| Domain | PWWP_dom | 3.63e-06 | 23 | 87 | 4 | IPR000313 | |
| Domain | PWWP | 4.35e-06 | 24 | 87 | 4 | PS50812 | |
| Domain | LEDGF | 2.14e-05 | 2 | 87 | 2 | PF11467 | |
| Domain | LEDGF | 2.14e-05 | 2 | 87 | 2 | IPR021567 | |
| Domain | GABAAb_rcpt | 6.42e-05 | 3 | 87 | 2 | IPR002289 | |
| Domain | Chaprnin_Cpn60 | 7.56e-04 | 9 | 87 | 2 | IPR001844 | |
| Domain | Ubox_domain | 9.42e-04 | 10 | 87 | 2 | IPR003613 | |
| Domain | C2_dom | 1.02e-03 | 164 | 87 | 5 | IPR000008 | |
| Domain | TUDOR | 1.88e-03 | 14 | 87 | 2 | PF00567 | |
| Domain | - | 1.88e-03 | 14 | 87 | 2 | 1.10.560.10 | |
| Domain | GROEL-like_equatorial | 1.88e-03 | 14 | 87 | 2 | IPR027413 | |
| Domain | Cpn60/TCP-1 | 2.17e-03 | 15 | 87 | 2 | IPR002423 | |
| Domain | Cpn60_TCP1 | 2.17e-03 | 15 | 87 | 2 | PF00118 | |
| Domain | - | 2.17e-03 | 15 | 87 | 2 | 3.50.7.10 | |
| Domain | GroEL-like_apical_dom | 2.17e-03 | 15 | 87 | 2 | IPR027409 | |
| Domain | DS_RBD | 4.25e-03 | 21 | 87 | 2 | PS50137 | |
| Domain | GABAA/Glycine_rcpt | 5.09e-03 | 23 | 87 | 2 | IPR006028 | |
| Domain | TUDOR | 5.09e-03 | 23 | 87 | 2 | PS50304 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | H1-10 URB1 SPATS2L PSIP1 CCT3 RBBP6 RRS1 STRBP RBMS2 NAF1 NUFIP2 CHD2 HSD17B10 PRKDC ANKHD1 MYEF2 SON HNRNPR | 3.06e-12 | 807 | 91 | 18 | 22681889 |
| Pubmed | HSPD1 RGPD2 FLNC STRN3 MYH6 PSIP1 CCT3 RRS1 STRBP AHNAK SLC44A2 ANKRD26 CHD2 FGFR1 RIMS1 PRKDC TAF4 KIAA2012 HDGFL2 RAI1 HNRNPR BAHCC1 | 1.50e-11 | 1442 | 91 | 22 | 35575683 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | HSPD1 H1-10 CAAP1 PSIP1 RBBP6 RRS1 STRBP RBMS2 AHNAK NUFIP2 NSD1 HSD17B10 PRKDC TAF4 HDGFL2 RAI1 SON HNRNPR | 4.75e-11 | 954 | 91 | 18 | 36373674 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | FLNC CAAP1 URB1 SPATS2L RRS1 STRBP RBMS2 AHNAK NUFIP2 ANKRD26 PPIL2 HSD17B10 ANKHD1 SRPRB SON HNRNPR | 6.46e-11 | 724 | 91 | 16 | 36232890 |
| Pubmed | H1-10 FLNC URB1 CCT3 RRS1 STRBP AHNAK NUFIP2 NSD1 CHD2 PRKDC ANKHD1 MYEF2 RAI1 SON | 1.59e-10 | 653 | 91 | 15 | 22586326 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | HSPD1 FLNC URB1 SPATS2L CCT3 RRS1 STRBP AHNAK UFD1 NUFIP2 PPIL2 HSD17B10 PRKDC LAP3 SON HDGF HNRNPR | 7.24e-10 | 989 | 91 | 17 | 36424410 |
| Pubmed | FLNC PSIP1 RBBP6 AHNAK PAFAH1B1 NUFIP2 APEH HDGFL2 LAP3 SON HDGF | 8.22e-09 | 399 | 91 | 11 | 35987950 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HSPD1 H1-10 FLNC URB1 PSIP1 CCT3 RRS1 STRBP AHNAK PRKCA HSD17B10 PRKDC SRPRB MYEF2 SON HNRNPR | 9.36e-09 | 1024 | 91 | 16 | 24711643 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HSPD1 ACSL1 H1-10 FLNC URB1 CCT3 RRS1 AHNAK PAFAH1B1 UFD1 PRKCA CHD2 PRKDC ANKHD1 SRPRB MYEF2 SON HNRNPR | 1.19e-08 | 1353 | 91 | 18 | 29467282 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | HSPD1 FLNC CAAP1 NPTX1 PSIP1 RBBP6 RRS1 CHD9 PPIL2 CHD2 PRKDC ZC3H6 MYEF2 SON HNRNPR | 1.35e-07 | 1082 | 91 | 15 | 38697112 |
| Pubmed | 1.38e-07 | 312 | 91 | 9 | 37120454 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | HSPD1 STRN3 PSIP1 CCT3 RBBP6 RRS1 AHNAK NAF1 NUFIP2 ANKRD26 PRKDC ANKHD1 HDGFL2 SON | 1.45e-07 | 934 | 91 | 14 | 33916271 |
| Pubmed | 1.73e-07 | 5 | 91 | 3 | 1321150 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HSPD1 METTL1 H1-10 FLNC STRN3 CCT3 AHNAK NAF1 PAFAH1B1 UFD1 APEH HSD17B10 PRKDC HDGFL2 LAP3 HDGF HNRNPR | 2.05e-07 | 1455 | 91 | 17 | 22863883 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | HSPD1 PREB H1-10 URB1 PSIP1 RBBP6 AHNAK NSD1 CHD2 PRKDC TAF4 HDGFL2 SRPRB RAI1 SON HNRNPR | 2.31e-07 | 1294 | 91 | 16 | 30804502 |
| Pubmed | 2.50e-07 | 441 | 91 | 10 | 31239290 | ||
| Pubmed | GABRB1 GABRB2 HSPD1 PREB RGPD2 STRN3 AMER2 RABGAP1L NUFIP2 ADGRB3 PRKCA HSD17B10 RIMS1 SRPRB MYEF2 | 2.61e-07 | 1139 | 91 | 15 | 36417873 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | HSPD1 H1-10 FLNC STRN3 CCT3 AHNAK PAFAH1B1 NUFIP2 HSD17B10 PRKDC ANKHD1 HDGFL2 LAP3 HDGF HNRNPR | 2.91e-07 | 1149 | 91 | 15 | 35446349 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | HSPD1 H1-10 CAAP1 CCT3 RBBP6 RRS1 AHNAK ECHDC1 CHD2 HSD17B10 PRKDC TAF4 SRPRB LAP3 SON HNRNPR | 2.96e-07 | 1318 | 91 | 16 | 30463901 |
| Pubmed | PREB STRN3 CAAP1 URB1 SPATS2L TBC1D10A RBBP6 RRS1 NUFIP2 NSD1 CHD2 HSD17B10 TAF4 ANKHD1 HDGFL2 MYEF2 SON | 3.06e-07 | 1497 | 91 | 17 | 31527615 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | HSPD1 H1-10 PSIP1 CCT3 RRS1 NUFIP2 HSD17B10 PRKDC ANKHD1 MYEF2 SON HNRNPR | 3.67e-07 | 714 | 91 | 12 | 28302793 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HSPD1 H1-10 PSIP1 CCT3 AHNAK NAF1 UFD1 PPIL2 HSD17B10 PRKDC ANKHD1 HDGFL2 SRPRB SON HDGF HNRNPR | 7.58e-07 | 1415 | 91 | 16 | 28515276 |
| Pubmed | HIV-1 integration: an interplay between HIV-1 integrase, cellular and viral proteins. | 9.61e-07 | 8 | 91 | 3 | 15875659 | |
| Pubmed | Model of full-length HIV-1 integrase complexed with viral DNA as template for anti-HIV drug design. | 9.61e-07 | 8 | 91 | 3 | 16075307 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | HSPD1 H1-10 CAAP1 PSIP1 CCT3 RBBP6 AHNAK NUFIP2 PPIL2 PRKDC TAF4 SON HNRNPR | 1.15e-06 | 949 | 91 | 13 | 36574265 |
| Pubmed | HSPD1 H1-10 CCT3 AHNAK UFD1 APEH PRKDC SRPRB LAP3 MYEF2 HDGF HNRNPR | 1.26e-06 | 803 | 91 | 12 | 36517590 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | HSPD1 H1-10 FLNC PSIP1 CCT3 DYNC2H1 AHNAK UFD1 TDRD10 HSD17B10 PRKDC MYEF2 | 1.32e-06 | 807 | 91 | 12 | 30575818 |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | H1-10 SPATS2L CCT3 RBBP6 RRS1 NAF1 NUFIP2 HSD17B10 MYEF2 SON HNRNPR | 1.64e-06 | 678 | 91 | 11 | 30209976 |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | HSPD1 PREB RGPD2 CAAP1 CCT3 RBBP6 NAF1 NUFIP2 HSD17B10 SRPRB MYEF2 | 2.26e-06 | 701 | 91 | 11 | 30196744 |
| Pubmed | 3.87e-06 | 245 | 91 | 7 | 35652658 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 4.62e-06 | 477 | 91 | 9 | 31300519 | |
| Pubmed | 5.57e-06 | 259 | 91 | 7 | 31162944 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 16337983 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 18439899 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 22532149 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 12196556 | ||
| Pubmed | Course of Brugia malayi infection in C57BL/6J NOS2 +/+ and -/- mice. | 6.77e-06 | 2 | 91 | 2 | 11426950 | |
| Pubmed | DNA damage promotes microtubule dynamics through a DNA-PK-AKT axis for enhanced repair. | 6.77e-06 | 2 | 91 | 2 | 33404607 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 25241062 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 19144640 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 17982083 | ||
| Pubmed | Protein kinase B phosphorylates AHNAK and regulates its subcellular localization. | 6.77e-06 | 2 | 91 | 2 | 11535620 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 21514331 | ||
| Pubmed | Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. | 6.77e-06 | 2 | 91 | 2 | 15262962 | |
| Pubmed | DNA-PK mediates AKT activation and apoptosis inhibition in clinically acquired platinum resistance. | 6.77e-06 | 2 | 91 | 2 | 22131882 | |
| Pubmed | LEDGF and HDGF2 relieve the nucleosome-induced barrier to transcription in differentiated cells. | 6.77e-06 | 2 | 91 | 2 | 31616795 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 27170493 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 36585107 | ||
| Pubmed | HRP-2 determines HIV-1 integration site selection in LEDGF/p75 depleted cells. | 6.77e-06 | 2 | 91 | 2 | 23046603 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 12406306 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 15797927 | ||
| Pubmed | Interaction of HRP-2 isoforms with HDGF: chromatin binding of a specific heteromer. | 6.77e-06 | 2 | 91 | 2 | 22212508 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 18644989 | ||
| Pubmed | RGPD2 STRN3 CCT3 NUFIP2 ADGRB3 NSD1 PRKCA RIMS1 TAF4 DNAJC6 MYEF2 RAI1 | 8.04e-06 | 963 | 91 | 12 | 28671696 | |
| Pubmed | 8.23e-06 | 652 | 91 | 10 | 31180492 | ||
| Pubmed | HSPD1 H1-10 RBBP6 RRS1 NUFIP2 PRKDC TAF4 ANKHD1 MYEF2 HNRNPR | 8.56e-06 | 655 | 91 | 10 | 35819319 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 9.91e-06 | 283 | 91 | 7 | 30585729 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | FLNC SPATS2L CCT3 RBMS2 AHNAK PAFAH1B1 APEH PRKCA HSD17B10 PRKDC HDGFL2 LAP3 SON HDGF | 1.24e-05 | 1367 | 91 | 14 | 32687490 |
| Pubmed | PSIP1 CCT3 RBBP6 AHNAK UFD1 CHD9 CHD2 PRKDC TAF4 HDGFL2 SON HDGF | 1.34e-05 | 1014 | 91 | 12 | 32416067 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | HSPD1 FLNC PSIP1 CCT3 RABGAP1L ADGRB3 HSD17B10 PRKDC ZNF804A HDGFL2 HDGF | 1.35e-05 | 847 | 91 | 11 | 35235311 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | GABRB2 HSPD1 CCT3 TBC1D10A DYNC2H1 AHNAK PAFAH1B1 SLC44A2 PRKCA ADGRV1 LAP3 SLC3A1 | 1.37e-05 | 1016 | 91 | 12 | 19056867 |
| Pubmed | 1.38e-05 | 547 | 91 | 9 | 37267103 | ||
| Pubmed | 1.46e-05 | 551 | 91 | 9 | 34728620 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | HSPD1 PREB H1-10 FLNC PSIP1 RBBP6 AHNAK PAFAH1B1 NUFIP2 CHD2 PRKDC SRPRB HNRNPR | 1.49e-05 | 1203 | 91 | 13 | 29180619 |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | HSPD1 CAAP1 SPATS2L PSIP1 CCT3 RRS1 NUFIP2 LAP3 MYEF2 HNRNPR | 1.59e-05 | 704 | 91 | 10 | 32994395 |
| Pubmed | HSPD1 PREB CCT3 AHNAK NUFIP2 ANKRD26 HSD17B10 PRKDC SRPRB HDGF | 1.67e-05 | 708 | 91 | 10 | 39231216 | |
| Pubmed | HSPD1 H1-10 SLC25A20 SPATS2L CCT3 PRKDC ANKHD1 HDGFL2 SRPRB HNRNPR | 1.74e-05 | 711 | 91 | 10 | 33022573 | |
| Pubmed | 1.78e-05 | 713 | 91 | 10 | 29802200 | ||
| Pubmed | 1.91e-05 | 60 | 91 | 4 | 32027825 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HSPD1 H1-10 URB1 PSIP1 CCT3 DYNC2H1 RRS1 HSD17B10 PRKDC ANKHD1 SRPRB LAP3 HDGF HNRNPR | 1.97e-05 | 1425 | 91 | 14 | 30948266 |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 38177536 | ||
| Pubmed | Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activation. | 2.03e-05 | 3 | 91 | 2 | 22957045 | |
| Pubmed | N-Glycosylation of GABAA receptor subunits is altered in Schizophrenia. | 2.03e-05 | 3 | 91 | 2 | 23917429 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 33477970 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 23303383 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 25264192 | ||
| Pubmed | SG2NA enhances cancer cell survival by stabilizing DJ-1 and thus activating Akt. | 2.03e-05 | 3 | 91 | 2 | 26022125 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 38760896 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 15371438 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 19781633 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 19324870 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 23135917 | ||
| Pubmed | GABAA receptor beta 1, beta 2, and beta 3 subunits: comparisons in DBA/2J and C57BL/6J mice. | 2.03e-05 | 3 | 91 | 2 | 7893750 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 1282920 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 18622039 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 21576322 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 21576342 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 18757368 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 12704190 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 16785234 | ||
| Pubmed | FGFR antagonist induces protective autophagy in FGFR1-amplified breast cancer cell. | 2.03e-05 | 3 | 91 | 2 | 26993162 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 9299445 | ||
| Pubmed | Expression and distribution of GABAA receptor subtypes in human alcoholic cerebral cortex. | 2.03e-05 | 3 | 91 | 2 | 11085308 | |
| Pubmed | GABAA receptor beta subunit mRNA expression in the human alcoholic brain. | 2.03e-05 | 3 | 91 | 2 | 15337300 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 22647853 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 25945695 | ||
| Pubmed | HSPD1 H1-10 FLNC CCT3 NUFIP2 HSD17B10 PRKDC SRPRB SON HNRNPR | 2.05e-05 | 725 | 91 | 10 | 27025967 | |
| Pubmed | HSPD1 H1-10 CCT3 RBBP6 NUFIP2 APEH CHD9 PPIL2 HSD17B10 PRKDC ZC3H6 HDGF HNRNPR | 2.18e-05 | 1247 | 91 | 13 | 27684187 | |
| Pubmed | 2.20e-05 | 731 | 91 | 10 | 29298432 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | HSPD1 H1-10 SPATS2L PSIP1 CCT3 RBMS2 ANKRD26 PRSS23 ANKHD1 MYEF2 | 2.22e-05 | 732 | 91 | 10 | 34732716 |
| Interaction | SMC5 interactions | HSPD1 H1-10 CAAP1 PSIP1 RBBP6 RRS1 STRBP RBMS2 AHNAK NUFIP2 NSD1 HSD17B10 PRKDC TAF4 HDGFL2 RAI1 SON HNRNPR | 3.07e-07 | 1000 | 89 | 18 | int:SMC5 |
| Interaction | SIRT7 interactions | H1-10 FLNC URB1 CCT3 RRS1 STRBP AHNAK NUFIP2 NSD1 CHD2 PRKDC ANKHD1 MYEF2 RAI1 SON | 8.42e-07 | 744 | 89 | 15 | int:SIRT7 |
| Interaction | AGR2 interactions | HSPD1 H1-10 FLNC PSIP1 CCT3 DYNC2H1 AHNAK UFD1 NSD1 TDRD10 HSD17B10 PRKDC NOS2 MYEF2 FABP2 HDGF | 2.92e-06 | 934 | 89 | 16 | int:AGR2 |
| Interaction | OBSL1 interactions | HSPD1 H1-10 FLNC URB1 SPATS2L PSIP1 CCT3 RRS1 STRBP AHNAK HSD17B10 PRKDC MYEF2 SON HNRNPR | 8.87e-06 | 902 | 89 | 15 | int:OBSL1 |
| Interaction | FGF11 interactions | 1.03e-05 | 170 | 89 | 7 | int:FGF11 | |
| Interaction | MECP2 interactions | HSPD1 FLNC CAAP1 URB1 NPTX1 PSIP1 RBBP6 RRS1 NUFIP2 NSD1 CHD9 PPIL2 CHD2 PRKDC ZC3H6 MYEF2 SON HNRNPR | 1.10e-05 | 1287 | 89 | 18 | int:MECP2 |
| Interaction | BAP1 interactions | HSPD1 H1-10 FLNC STRN3 CCT3 AHNAK PAFAH1B1 NUFIP2 MEIOB PRKCA AKT1 HSD17B10 PRKDC ANKHD1 HDGFL2 LAP3 HDGF HNRNPR | 1.45e-05 | 1314 | 89 | 18 | int:BAP1 |
| Interaction | CIT interactions | HSPD1 H1-10 FLNC URB1 PSIP1 CCT3 RBBP6 DYNC2H1 RRS1 STRBP AHNAK NUFIP2 CHD2 PRKDC ADGRV1 OSGIN2 HDGFL2 SON HNRNPR | 1.50e-05 | 1450 | 89 | 19 | int:CIT |
| Interaction | VARS1 interactions | 1.98e-05 | 260 | 89 | 8 | int:VARS1 | |
| Interaction | MYCN interactions | HSPD1 H1-10 SPATS2L PSIP1 CCT3 RBBP6 RRS1 STRBP RBMS2 NUFIP2 CHD2 PRKDC HDGFL2 MYEF2 RAI1 SON HDGF HNRNPR | 2.62e-05 | 1373 | 89 | 18 | int:MYCN |
| Interaction | KCNA3 interactions | HSPD1 PREB CCT3 RBBP6 AHNAK NUFIP2 ANKRD26 CHD9 CHD2 HSD17B10 RIMS1 PRKDC SRPRB HDGF | 2.67e-05 | 871 | 89 | 14 | int:KCNA3 |
| Interaction | RICTOR interactions | HSPD1 RGPD2 FLNC STRN3 CCT3 RRS1 AHNAK PRKCA AKT1 HSD17B10 PRKDC ANKHD1 SRPRB | 2.77e-05 | 759 | 89 | 13 | int:RICTOR |
| Interaction | H1-2 interactions | H1-10 URB1 RRS1 STRBP AHNAK PAFAH1B1 NSD1 APEH PRKCA PRKDC ZC3H6 HDGF | 3.56e-05 | 666 | 89 | 12 | int:H1-2 |
| Interaction | RBM39 interactions | HSPD1 H1-10 CAAP1 PSIP1 CCT3 RRS1 NUFIP2 HSD17B10 PRKDC ANKHD1 LAP3 MYEF2 SON HDGF HNRNPR | 4.77e-05 | 1042 | 89 | 15 | int:RBM39 |
| Interaction | H2AC4 interactions | 7.85e-05 | 506 | 89 | 10 | int:H2AC4 | |
| Interaction | MIR19A interactions | 8.12e-05 | 100 | 89 | 5 | int:MIR19A | |
| Interaction | NAA40 interactions | HSPD1 STRN3 PSIP1 CCT3 RBBP6 RRS1 AHNAK NAF1 NUFIP2 ANKRD26 PRKDC ANKHD1 HDGFL2 SON | 9.34e-05 | 978 | 89 | 14 | int:NAA40 |
| Interaction | NUP43 interactions | 9.52e-05 | 625 | 89 | 11 | int:NUP43 | |
| Interaction | MAPT interactions | HSPD1 H1-10 FLNC NPTX1 CCT3 AHNAK PAFAH1B1 UFD1 NUFIP2 APEH PRKCA AKT1 HSD17B10 RIMS1 HNRNPR | 1.07e-04 | 1119 | 89 | 15 | int:MAPT |
| Interaction | ITGB3 interactions | 1.07e-04 | 170 | 89 | 6 | int:ITGB3 | |
| Interaction | CBX3 interactions | HSPD1 PSIP1 RBBP6 RRS1 NSD1 CHD9 PPIL2 TAF4 HDGFL2 LAP3 HDGF | 1.27e-04 | 646 | 89 | 11 | int:CBX3 |
| Interaction | FLT1 interactions | 1.43e-04 | 179 | 89 | 6 | int:FLT1 | |
| Interaction | PRNP interactions | HSPD1 FLNC STRN3 AMER2 NPTX1 RBMS2 ECHDC1 NAF1 APEH POC5 BCAS1 TAF4 ZC3H6 MYEF2 HDGF | 1.55e-04 | 1158 | 89 | 15 | int:PRNP |
| Interaction | MAGEB2 interactions | 1.56e-04 | 349 | 89 | 8 | int:MAGEB2 | |
| Interaction | NHERF1 interactions | 1.61e-04 | 183 | 89 | 6 | int:NHERF1 | |
| Interaction | SCARNA22 interactions | 1.77e-04 | 118 | 89 | 5 | int:SCARNA22 | |
| Interaction | PINK1 interactions | HSPD1 ACSL1 FLNC CCT3 AHNAK NUFIP2 AKT1 HSD17B10 PRKDC SON HNRNPR | 1.97e-04 | 679 | 89 | 11 | int:PINK1 |
| Interaction | KIF20A interactions | HSPD1 FLNC URB1 PSIP1 RBBP6 DYNC2H1 RRS1 AHNAK RABGAP1L NUFIP2 CHD2 PRKDC SON HNRNPR | 2.00e-04 | 1052 | 89 | 14 | int:KIF20A |
| Interaction | PFKFB1 interactions | 2.01e-04 | 26 | 89 | 3 | int:PFKFB1 | |
| Interaction | NPM1 interactions | H1-10 FLNC URB1 SPATS2L PSIP1 RRS1 NUFIP2 NSD1 PRKCA CCDC80 AKT1 PRKDC NOS2 SON HNRNPR | 2.31e-04 | 1201 | 89 | 15 | int:NPM1 |
| Interaction | CENPA interactions | 2.63e-04 | 377 | 89 | 8 | int:CENPA | |
| Interaction | TNIP1 interactions | HSPD1 H1-10 CAAP1 PSIP1 CCT3 RBBP6 AHNAK NUFIP2 APEH PPIL2 PRKDC TAF4 SON HDGF HNRNPR | 2.67e-04 | 1217 | 89 | 15 | int:TNIP1 |
| Interaction | DCAF4 interactions | 2.68e-04 | 378 | 89 | 8 | int:DCAF4 | |
| Interaction | DDX23 interactions | 2.69e-04 | 480 | 89 | 9 | int:DDX23 | |
| Interaction | TIAM2 interactions | 2.80e-04 | 29 | 89 | 3 | int:TIAM2 | |
| Interaction | PSIP1 interactions | 2.97e-04 | 205 | 89 | 6 | int:PSIP1 | |
| Interaction | MIR29B1 interactions | 3.07e-04 | 73 | 89 | 4 | int:MIR29B1 | |
| Interaction | USP14 interactions | 3.09e-04 | 489 | 89 | 9 | int:USP14 | |
| Interaction | WDR5 interactions | HSPD1 H1-10 SLC25A20 SPATS2L PSIP1 CCT3 PAFAH1B1 PRKDC TAF4 ANKHD1 HDGFL2 SRPRB HDGF HNRNPR | 3.19e-04 | 1101 | 89 | 14 | int:WDR5 |
| Interaction | BRD3 interactions | 3.32e-04 | 494 | 89 | 9 | int:BRD3 | |
| Interaction | PRC1 interactions | HSPD1 H1-10 FLNC URB1 PSIP1 CCT3 RBBP6 RRS1 STRBP AHNAK PRKDC SON HNRNPR | 3.33e-04 | 973 | 89 | 13 | int:PRC1 |
| Interaction | DDRGK1 interactions | HSPD1 PREB H1-10 CAAP1 SPATS2L PSIP1 CCT3 RRS1 STRBP FGFR1 HSD17B10 PRKDC SRPRB MYEF2 HNRNPR | 3.52e-04 | 1249 | 89 | 15 | int:DDRGK1 |
| Interaction | CHMP4B interactions | HSPD1 H1-10 FLNC URB1 STRBP AHNAK HSD17B10 PRKDC PRSS23 SON HNRNPR | 3.53e-04 | 727 | 89 | 11 | int:CHMP4B |
| Cytoband | 2q33.1 | 1.46e-04 | 51 | 91 | 3 | 2q33.1 | |
| GeneFamily | PWWP domain containing | 3.32e-05 | 22 | 52 | 3 | 1147 | |
| GeneFamily | Chaperonins | 8.32e-04 | 15 | 52 | 2 | 587 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 1.34e-03 | 19 | 52 | 2 | 563 | |
| GeneFamily | RNA binding motif containing | 3.26e-03 | 213 | 52 | 4 | 725 | |
| GeneFamily | Tudor domain containing | 5.07e-03 | 37 | 52 | 2 | 780 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | GABRB1 PREB METTL1 MYH6 NPTX1 SLC25A20 AHNAK ECHDC1 PRKCA CCDC80 PPIL2 RIMS1 PRSS23 HDGFL2 SRPRB | 6.14e-06 | 1136 | 89 | 15 | M2247 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | GABRB1 PREB METTL1 MYH6 NPTX1 SLC25A20 AHNAK ECHDC1 PRKCA CCDC80 PPIL2 RIMS1 PRSS23 HDGFL2 SRPRB | 1.16e-05 | 1198 | 89 | 15 | MM1062 |
| Coexpression | SANA_RESPONSE_TO_IFNG_DN | 1.20e-05 | 87 | 89 | 5 | M9583 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.63e-08 | 176 | 91 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | RV-16._Neuronal|World / Chamber and Cluster_Paper | 6.30e-07 | 149 | 91 | 6 | 3a2f8c4173dcf9e3f8d3b8ffddbc597098adf7a9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-06 | 185 | 91 | 6 | c083a4974590b9ed3ecafedd3e9cdebc5047fe39 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 186 | 91 | 6 | a1ab273b01971d6a892912560d387685dd657179 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-06 | 187 | 91 | 6 | ef3c85c01bc3da408ae288b6e3096ad888a12e63 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-06 | 189 | 91 | 6 | 3d838da870623a6a278ddc8e6cedca85d9877e50 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.29e-06 | 198 | 91 | 6 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 148 | 91 | 5 | f58804d24fe524b42b5090c8658050ea4b14793e | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_D|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.38e-05 | 149 | 91 | 5 | dcf68eb25733b5db2893728fe4dca5c7267eb58c | |
| ToppCell | RV-16._Neuronal|RV / Chamber and Cluster_Paper | 1.56e-05 | 153 | 91 | 5 | bed8bbf5c5cbfbf46a816066da472c3fdddecb5d | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.32e-05 | 166 | 91 | 5 | 545f6c91102568791443717e522f89cb3bd1a070 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 2.45e-05 | 168 | 91 | 5 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 2.45e-05 | 168 | 91 | 5 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.15e-05 | 177 | 91 | 5 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.15e-05 | 177 | 91 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.32e-05 | 179 | 91 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 3.41e-05 | 180 | 91 | 5 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 180 | 91 | 5 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | 3.50e-05 | 181 | 91 | 5 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 183 | 91 | 5 | 92ef926e6c1de8477fa4f35d1dae85482d8009de | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 183 | 91 | 5 | 24db9cc717e651586317c6a8e03a3401651273c1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 186 | 91 | 5 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.99e-05 | 186 | 91 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-05 | 189 | 91 | 5 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | NS-critical-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.64e-05 | 192 | 91 | 5 | 02b11233b4da2d85b96498b3c6e22e3a31b3d049 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 193 | 91 | 5 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.87e-05 | 194 | 91 | 5 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | droplet-Marrow-BM-1m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-05 | 195 | 91 | 5 | 637b06ef3967b03f7165d102d316e8b7161a817d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.99e-05 | 195 | 91 | 5 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | COVID-19_Severe|World / Disease condition and Cell class | 5.12e-05 | 196 | 91 | 5 | 450ac2aff89c5ca73b8bfbc80663e03be066931f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.12e-05 | 196 | 91 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 5.24e-05 | 197 | 91 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | CV-Mild-2|CV / Virus stimulation, Condition and Cluster | 5.24e-05 | 197 | 91 | 5 | dc1cfba2ee66c62b53accefbfce3025cd760524a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.37e-05 | 198 | 91 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.37e-05 | 198 | 91 | 5 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | CV-Moderate-2|CV / Virus stimulation, Condition and Cluster | 5.50e-05 | 199 | 91 | 5 | 2d98424a5247e87f98095c11fb945289092a9d75 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.50e-05 | 199 | 91 | 5 | 1e693d7bb481bf03a943b460a69787229625d7b1 | |
| ToppCell | CD8+_Memory_T_cell-CV-2|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 5.50e-05 | 199 | 91 | 5 | 1e33d8e2e0d6a54ef6e2e13f986e19fd209275a8 | |
| ToppCell | CV-Moderate-2|Moderate / Virus stimulation, Condition and Cluster | 5.50e-05 | 199 | 91 | 5 | 70d6f2a328eec4cb2cecb7cd85859fba9e15c9c8 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.50e-05 | 199 | 91 | 5 | f3cc3cda38f78d1d12d865df339d93c5fecf19f2 | |
| ToppCell | CV-Mild-2|Mild / Virus stimulation, Condition and Cluster | 5.50e-05 | 199 | 91 | 5 | d88cc07053a852e6c468538a0a851ffa09f97a0d | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 5.50e-05 | 199 | 91 | 5 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | Int-URO-Myeloid-cDC2|Int-URO / Disease, Lineage and Cell Type | 5.50e-05 | 199 | 91 | 5 | 7bbeda66f522b803f85be65d1a81555e12585efc | |
| ToppCell | Sepsis-Int-URO-Myeloid-cDC2|Int-URO / Disease, condition lineage and cell class | 5.63e-05 | 200 | 91 | 5 | dd8ac355b3b0394fda005789f9f2ff6560a02dac | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.40e-05 | 105 | 91 | 4 | 8f31edf4183587f5b53941475453c5aa49f10bbd | |
| Disease | schizophrenia (implicated_via_orthology) | 5.20e-05 | 68 | 88 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | bipolar disorder | NPTX1 SPATS2L SLC44A2 PRKCA WFDC5 FGFR1 RIMS1 ANKHD1 ZNF804A | 5.69e-05 | 577 | 88 | 9 | MONDO_0004985 |
| Disease | paraplegia (biomarker_via_orthology) | 8.74e-05 | 5 | 88 | 2 | DOID:607 (biomarker_via_orthology) | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 1.83e-04 | 7 | 88 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Endotoxemia | 2.43e-04 | 8 | 88 | 2 | C0376618 | |
| Disease | autistic disorder (is_implicated_in) | 2.70e-04 | 42 | 88 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | Schizophrenia | GABRB1 GABRB2 PAFAH1B1 UFD1 NUFIP2 PRKCA AKT1 FGFR1 ZNF804A RAI1 | 3.00e-04 | 883 | 88 | 10 | C0036341 |
| Disease | Adenocarcinoma of lung (disorder) | 3.87e-04 | 206 | 88 | 5 | C0152013 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 5.94e-04 | 128 | 88 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 5.94e-04 | 128 | 88 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 5.94e-04 | 128 | 88 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 5.94e-04 | 128 | 88 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 5.94e-04 | 128 | 88 | 4 | C0007134 | |
| Disease | Fulminant Hepatic Failure with Cerebral Edema | 6.71e-04 | 13 | 88 | 2 | C0751197 | |
| Disease | Hepatic Stupor | 6.71e-04 | 13 | 88 | 2 | C0751198 | |
| Disease | Hepatic Encephalopathy | 6.71e-04 | 13 | 88 | 2 | C0019151 | |
| Disease | Hepatic Coma | 6.71e-04 | 13 | 88 | 2 | C0019147 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 9.00e-04 | 15 | 88 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.02e-03 | 148 | 88 | 4 | C0279702 | |
| Disease | Autistic Disorder | 1.12e-03 | 261 | 88 | 5 | C0004352 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.13e-03 | 152 | 88 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Drug-Induced Liver Disease | 1.34e-03 | 404 | 88 | 6 | C0860207 | |
| Disease | Drug-Induced Acute Liver Injury | 1.34e-03 | 404 | 88 | 6 | C3658290 | |
| Disease | Hepatitis, Toxic | 1.34e-03 | 404 | 88 | 6 | C0019193 | |
| Disease | Chemically-Induced Liver Toxicity | 1.34e-03 | 404 | 88 | 6 | C4279912 | |
| Disease | Chemical and Drug Induced Liver Injury | 1.34e-03 | 404 | 88 | 6 | C4277682 | |
| Disease | Hepatitis, Drug-Induced | 1.34e-03 | 404 | 88 | 6 | C1262760 | |
| Disease | bipolar disorder, schizophrenia, response to lithium ion | 1.61e-03 | 20 | 88 | 2 | GO_0010226, MONDO_0004985, MONDO_0005090 | |
| Disease | dilated cardiomyopathy | 1.61e-03 | 20 | 88 | 2 | EFO_0000407 | |
| Disease | Epilepsy, Cryptogenic | 1.91e-03 | 82 | 88 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 1.91e-03 | 82 | 88 | 3 | C0751111 | |
| Disease | Aura | 1.91e-03 | 82 | 88 | 3 | C0236018 | |
| Disease | cigarettes per day measurement | 2.01e-03 | 438 | 88 | 6 | EFO_0006525 | |
| Disease | TEMPS-A questionnaire | 2.52e-03 | 25 | 88 | 2 | EFO_0004783 | |
| Disease | Hypertrophic obstructive cardiomyopathy | 2.52e-03 | 25 | 88 | 2 | C4551472 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 2.71e-03 | 801 | 88 | 8 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | methionine measurement | 2.73e-03 | 26 | 88 | 2 | EFO_0009771 | |
| Disease | Neurodevelopmental Disorders | 2.74e-03 | 93 | 88 | 3 | C1535926 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.80e-03 | 195 | 88 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | age-related hearing impairment | 2.88e-03 | 324 | 88 | 5 | EFO_0005782 | |
| Disease | lissencephaly (implicated_via_orthology) | 2.94e-03 | 27 | 88 | 2 | DOID:0050453 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VVGSKGDRKKLPAGN | 96 | Q9BXT4 | |
| NDKEKDKAGGRLPSG | 36 | Q8N814 | |
| KDPKQRLGGGSEDAK | 386 | P31749 | |
| DRGEAGSLQKGPKDF | 201 | Q9P281 | |
| LLKKNGRSENGKGEP | 166 | Q8N7J2 | |
| SRGFKLFPGKDNSNK | 456 | Q7Z407 | |
| TNFPGLQKKGEEDQK | 136 | O60242 | |
| LGKDSGLKPFEQVKG | 641 | P33121 | |
| EGNKLIGKFKRTDNG | 86 | P12104 | |
| FKVQLKNPKGGAEIG | 3621 | Q8WXG9 | |
| KKKNGNATGEDFCGP | 826 | A8MVX0 | |
| KAKKQGFDLNVPGGE | 5036 | Q09666 | |
| NKQPEGLELKQGKGE | 236 | Q9H8G2 | |
| KAPGFGDNRKNQLKD | 301 | P10809 | |
| PLAGAADGKEKNIGN | 436 | Q9UPS8 | |
| RGTKDGIQNAFLKGP | 116 | Q96NB1 | |
| KKGGKTEQDGYQKPT | 586 | Q76M96 | |
| PDKLGGKQRAAFKSG | 1081 | Q7Z5J4 | |
| KISEKGLSFENGKGP | 1121 | Q96L73 | |
| KKYGTNPSNGEKLDG | 71 | Q13356 | |
| FQPVGSKDGAQKRAG | 91 | Q8IVA1 | |
| KFADGGPKKRQNQGK | 216 | Q15434 | |
| KEEFTSGGPLGQKRD | 76 | P43034 | |
| EKGQKDNRPGDKFQL | 216 | Q15818 | |
| GKANKPGDVVRAKNG | 341 | P28838 | |
| GKTDVKGFPDRKNIG | 31 | Q8N635 | |
| GDCPGNGEKLKKSLF | 596 | P35228 | |
| TNNKKEEYGPGVQGK | 381 | Q8NA72 | |
| KGEKGQPQELGRRFA | 191 | Q9NTI7 | |
| YNEIPKNGKGSTRKG | 396 | Q9NQ76 | |
| LNEKQRFPSKGKSQG | 421 | Q9NQ76 | |
| QRGFGKFGELLKPQK | 521 | A6NIV6 | |
| GGPANLEAIAKKGKF | 291 | Q9NTX5 | |
| NGSFKLNRKKLEGGG | 111 | Q92522 | |
| PEGKPKKANIRDNGD | 1581 | Q14315 | |
| EKFGKPNKRKGFSEG | 71 | P51858 | |
| GKRKADGYNQPDSKR | 571 | O43390 | |
| GGAFPNRKADLSDKQ | 326 | Q0VF49 | |
| FGFGLGKKLQQKHPE | 91 | O43772 | |
| NKLAGKNKGFPLGCT | 56 | Q8N8V2 | |
| FFGKGPQKKGASKQD | 331 | P18505 | |
| FGRGPQRQKKAAEKA | 331 | P47870 | |
| DKYGKPNKRKGFNEG | 66 | Q7Z4V5 | |
| DLPNSGGEAQAKKLG | 41 | Q99714 | |
| DGKGNFSPVPKDRDK | 286 | Q5R372 | |
| TNGDKNFESGPRIKK | 176 | Q7Z6E9 | |
| RKKTPGLSEQNGKGA | 271 | Q86UR5 | |
| PEFGAAINKGKLRGK | 286 | Q9Y236 | |
| KGYGGRQKLPDNLKQ | 1796 | Q8NCM8 | |
| KQGLAQKRPFDGEDG | 2361 | Q3L8U1 | |
| QLKENASEGKGPGKR | 1191 | O14647 | |
| LKNGKEFKPDHRIGG | 191 | P11362 | |
| LSGQGFNAHKDKKGP | 786 | O75061 | |
| GEFCGQKGTKNENKP | 71 | Q8IWA5 | |
| DIPKGKGKQFDAQGH | 846 | Q49AJ0 | |
| PEKRQQSLGGFFKGL | 546 | O75363 | |
| GLNQKPEKGENGIRF | 476 | P46059 | |
| KIANGVPNSKGDKGN | 566 | Q9UPX6 | |
| QKNKLKEPGGGSFRD | 816 | O00268 | |
| GGESPKQKGQEIKRS | 226 | Q13033 | |
| APAQLGKKGKEFEFS | 221 | Q9Y5M8 | |
| PKNKGGAKNQEASLG | 481 | Q9NUQ6 | |
| LRQKFEKAKLGPAGN | 301 | P17252 | |
| DKNSGAGEKKGPNRN | 86 | Q9P2K5 | |
| KDPNFKGFSGAGEKL | 981 | P0DJD1 | |
| GKNGVLEEQKSPGFK | 16 | Q5VZ19 | |
| KKALEFQDLGNKGQP | 451 | Q8NE18 | |
| KPKFKDGGRGANDST | 196 | O95084 | |
| FKDSNKDGNGDLKGI | 131 | Q07837 | |
| HKKKGDDQSRQGGAP | 526 | P49368 | |
| EVDGQKFRGAGPNKK | 546 | Q96SI9 | |
| IGDRGKKDNANANKG | 201 | P13533 | |
| PQSKHKELRAGKGNG | 396 | A0A1B0GV85 | |
| DDKKGQKRSDGPPAA | 526 | O60287 | |
| LRKAGGTGPGEEKQF | 106 | P13798 | |
| QKADKNKINGEPRGG | 1571 | Q8IWZ3 | |
| GKEAKKAGPGFHRQL | 141 | Q8N4M7 | |
| EKYGKPNKRKGFNEG | 66 | O75475 | |
| EKAGSKEQGPRQRKG | 106 | Q9HCU5 | |
| GSQLPAVFGRKKGEK | 16 | Q8TCV5 | |
| KLEQQEKGKGHTFPG | 196 | Q86Y38 | |
| SGAKLGDPRLQKNFD | 956 | P61129 | |
| AGGNGLKKNFLEKSP | 1991 | Q8NB66 | |
| ETPKKKTGYGELNGN | 86 | Q7Z417 | |
| RGSGKKRKFQPLFGD | 246 | Q15050 | |
| GKKRLGLPGDEVDNK | 2701 | P78527 | |
| SGNRLDGKKKGVEPS | 231 | Q92890 | |
| GGKVKLQQNPGKFDE | 126 | Q9BXI6 | |
| GEGLGKNKEGNKEPI | 2321 | P18583 | |
| GKKVLRNGGKNFPAI | 241 | Q9UBP6 | |
| KDKLGKQPERAGEGA | 131 | Q8IZ20 | |
| IKGVFRGPLSKNGNK | 21 | Q7Z570 | |
| IQGRKKLKSEFNEPG | 331 | Q96HR8 |